Generic pharma plaintiffs say states’ Teva case should be among first tried

Drug purchasers suing generic pharmaceutical companies for an alleged antitrust conspiracy have told a federal judge that the case brought by a large group of state attorneys general centred on Teva Pharmaceuticals should be among the first to go to trial.


Get unlimited access to all Global Competition Review content